Aspirion, the healthcare technology revenue cycle management (“RCM”) leader for denials, payment variance, and complex claims, announced the appointment of Scott Doolittle as its Chief Financial Officer (“CFO”) effective immediately. As CFO and member of the Aspirion executive leadership team, Doolittle will oversee all financial operations, strategic financial planning, and growth initiatives for the company.
“In Scott, we’ve found a financial strategist who understands the economic realities facing hospital CFOs and revenue cycle leaders today,” said Nick Giannasi, CEO of Aspirion. “His experience scaling healthcare technology companies through private equity partnerships directly mirrors Aspirion’s trajectory. What impressed us most was his track record building high-performance finance operations that don’t just report numbers—they drive strategic growth and create tangible financial impact.”
Doolittle brings substantial financial leadership experience from the healthcare sector, most recently as CFO at Quantum Health, where he led significant financial growth. During his tenure, Quantum Health achieved 10x revenue growth while maintaining a strong margin in today’s competitive healthcare market. His approach balanced strategic M&A with organic growth initiatives that align with current industry trends. Doolittle holds a master’s degree in international business studies from the University of South Carolina, a bachelor’s degree in finance from Miami University, and is a Chartered Financial Analyst.
Also Read: Credit Benchmark Accelerates Global Growth with Appointment of Mats Ellefsen as Head of Sales
“Hospital revenue cycle leaders are fighting an uphill battle against increasingly sophisticated denial tactics from payers,” said Doolittle. “What attracted me to Aspirion is their proven ability to level this playing field through both technology and expertise. My focus will be ensuring we can rapidly scale these solutions while maintaining the financial discipline needed to continue investing in innovation that delivers measurable ROI for our hospital partners.”
With more than 1,000 healthcare provider partnerships nationwide and over $6 billion in recovered claims revenue that would otherwise be written off, Aspirion has established itself as a critical financial lifeline for hospitals struggling with resource constraints and margin pressures. The company brings together cutting-edge AI, advanced automation, and deep human expertise to address denied and complex claims, providing a strategic alternative to adding headcount in an environment where qualified revenue cycle talent remains scarce and expensive.
SOURCE: PRNewswire
